ClinicalTrials.gg
CompletedNCT02153008Updated Aug 3, 2017

Strep A FIA Field Study, Sofia

An observational study in Group A Streptococcus, sponsored by Quidel Corporation. Completed at 7 sites in United States. Open to participants aged 3 Years and older. Per ClinicalTrials.gov, last updated 2017-08-03.

Sponsored by Quidel Corporation · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,708
Ages
3 Years and older
Sex
All
01

Study summary

To demonstrate the clinical performance of the Strep A FIA and Sofia, using throat swabs collected from symptomatic subjects.

02

Conditions studied

  • Group A Streptococcus

Keywords

  • Strep throat
03

In context

Lead sponsor

Quidel Corporation is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects will be recruited from the general population as they present to the clinical facility. Subjects must be exhibiting symptoms characteristic of pharyngitis, possibly GAS.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male and Female, 3 years of age or older
  2. Must currently be exhibiting one or more of the symptoms characteristic of pharyngitis to be eligible for inclusion in this study.

For example:

  1. Acute onset of sore throat
  2. Redness of the posterior pharyngeal wall
  3. Difficulty/pain on swallowing
  4. Fever, > 37.8º C (100ºF) at presentation or within past 24 hours
  5. Pharyngeal exudate
  6. Tender cervical lymphadenopathy
  7. Absence of cough, runny nose or other upper respiratory symptoms.*
  8. Other, symptoms specific to Strep A not listed above.

    • Must include at least one additional symptom from a-f and cannot be the only criteria used to meet inclusion for enrollment in the study.

Exclusion criteria

Exclusion Criteria:

  1. Subjects currently under treatment with antibiotics are not to be included in this study.
  2. At clinical sites requiring , unable to understand and consent to participation; for minors this includes parent or legal guardian.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,708 participants (actual)
Patient registry
No

Groups and cohorts

  • Symptomatic population for GAS

    This study is a diagnostic study to aid in the detection of Strep throat. No intervention or medication is a part of this study.

06

What researchers measure

Primary outcomes

  1. Detection of Group A Streptococcus

    A throat swab specimen will be obtained and tested for the presence of Group A Streptococcus via the Sofia Analyzer

    Time frame: Within 5 minutes

07

Study locations

7 sites
  • Best Medical Group, LLC
    Phoenix, Arizona 85042-6510, United States
  • Gentle Medical Associates
    Boynton Beach, Florida 33435, United States
  • Pediatrics by the Sea
    Delray Beach, Florida 33483, United States
  • Teena Hughes, MD
    Tampa, Florida 33613, United States
  • Twelve Corners Pediatrics
    Rochester, New York 14618, United States
  • Veritas, PA
    Belton, Texas 76513, United States
  • Advanced Pediatrics
    Vienna, Virginia 22180, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02153008
Lead sponsor
Quidel Corporation
Responsible party
Sponsor
First posted
Jun 2, 2014
Start date
Apr 2014
Primary completion
Jul 1, 2016
Completion
Jul 1, 2016
Last update
Aug 3, 2017

Study contacts

John D. Tamerius, PhD
study director · Quidel Corporation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion